Ernexa Therapeutics ERNAW
NASDAQ ERNAW
$0.06 +0.01 (+25.27%)
As of: Sep 4, 2026 · 3:55 PM EDT

Ernexa Therapeutics (ERNAW) Treasury Shares (2010 - 2022)

Ernexa Therapeutics' (ERNAW) quarterly Treasury Shares came in at $456000.0 in Q4 2020, little changed YoY from $456000.0 in Q1 2020, and little changed on a QoQ basis from $456000.0 in Q3 2020.

Analysis

Ernexa Therapeutics (ERNAW) Treasury Shares (2010 - 2022) Analysis & Trends

Ernexa Therapeutics (ERNAW) has 11 years of Treasury Shares data on file, last reported at $456000.0 in Q4 2020.

  • Quarterly Treasury Shares changed 0.0% year-over-year to $456000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $456000.0 (changed 0.0% YoY) and the FY2020 annual result came in at $456000.0, changed 0.0% from the prior year.
  • Treasury Shares steadied at $456000.0 in Q4 2020, from $456000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.3 million in Q1 2022 to a low of $500.0 in Q1 2025.
  • A 5-year average of $156576.9 and a median of $4000.0 in 2022 frame the typical range for Treasury Shares.
  • The widest YoY moves for Treasury Shares: up 0.0% in 2016, down 0.0% in 2016.
  • Tracing ERNAW's Treasury Shares over 5 years: stood at $456000.0 in 2016, then changed by 0.0% to $456000.0 in 2017, then changed by 0.0% to $456000.0 in 2018, then changed by 0.0% to $456000.0 in 2019, then changed by 0.0% to $456000.0 in 2020.
  • The last three Treasury Shares figures came in at $456000.0 (Q4 2020), $456000.0 (Q3 2020), and $456000.0 (Q1 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Ernexa Therapeutics 67,312.70 67,312.70 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 914.00
Mar 31, 2022 914.00
Dec 31, 2020 10,000.00
Dec 31, 2020 10,000.00
Dec 31, 2020 456,000.00
Dec 31, 2020 456,000.00
Sep 30, 2020 456,000.00
Sep 30, 2020 10,000.00
Sep 30, 2020 10,000.00
Sep 30, 2020 456,000.00
Mar 31, 2020 10,000.00
Mar 31, 2020 10,000.00
Mar 31, 2020 456,000.00
Mar 31, 2020 456,000.00
Dec 31, 2019 456,000.00
Dec 31, 2019 456,000.00
Dec 31, 2019 10,000.00
Dec 31, 2019 10,000.00
Sep 30, 2019 10,000.00
Sep 30, 2019 456,000.00